Clinical Trials in Houston

Showing 10481-10500 of 15,366 trials

Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme

NCT00038493

This study will combine the chemotherapy agent temozolomide with the investigational drug SCH66336 (an agent which interferes with new cell growth). Patients will be treated with oral temozolomide on days 1-5 and oral SCH66336 on days 8-28 every 28 days.

Glioblastoma Multiforme

M.D. Anderson Cancer Center23 participantsStarted Sep 2001

Houston, Texas, United States

COMPLETEDPhase 1< 1 mile

Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis

NCT01585766

The purpose of this study is to evaluate the safety and tolerability of ascending intravenous (IV) and subcutaneous (SC) doses of MEDI-551 in adult subjects with relapsing forms of multiple sclerosis (MS).

Multiple Sclerosis, Relapsing Forms

MedImmune LLC56 participantsStarted Apr 2012

Scottsdale, Arizona, United States • Long Beach, California, United States • Sacramento, California, United States +13 more locations

Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme

Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis

Find Trials by Condition in Houston

Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies

Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Amifostine in Treating Patients With Myelodysplastic Syndrome

Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer

LC Bead Embolization Agent With Doxorubicin in the Treatment Liver Metastasis From Melanoma

CHESS: Human and Computer Mentors for Prostate Cancer Patients

Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach

Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease

Fatigue and Symptom Burden in Low-Risk Cancer Patients Undergoing Treatment for Febrile Neutropenia

Vidaza to Restore Hormone Thx Prostate

Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients

A Study in Subjects With Moderate Atopic Dermatitis

A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake Inhibitors

Safety and Efficacy of OMS103HP-S Administered in Joint Irrigation Solution to Subjects Undergoing Arthroscopic Meniscectomy

Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients

Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Intraabdominal Infections

Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis

PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C